What are you looking for?
Dosage & Administration
One dose, once daily, swallowed whole with a glass of water in the morning, approximately 30 to 60 minutes before eating your first meal of the day.
Dosage
Dosage is to be decided by the attending physician.
Adult Dosage: Typically 500 mg twice daily, with dose titration to achieve optimal therapeutic effect.
Possible Side Effects
During clinical studies, gastrointestinal conditions such as diarrhea, nausea, and vomiting were generally mild, suggesting Imeglimin is well tolerated.
Due to its direct mitochondrial inhibition, mild transient reactions may occur as treatment progresses.
Administration Procedure
With Meals: Tablets should be taken with meals.
With Water: Administer with a full glass of water.
Do Not Alter Tablets: Do not crush, split, or chew Imeglimin potassium tablets, as this may affect drug performance.
Safety & Caution
Renal Function: As Imeglimin is primarily excreted via the kidneys, monitoring of eGFR (estimated glomerular filtration rate) is essential, especially in chronic kidney disease (CKD). Dose adjustments may be required.
Alcohol: Avoid alcohol, as it may increase the risk of hypoglycemia and lactic acidosis.
Pregnancy/Lactation: Inform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding before starting treatment.
Potential Side Effects
Most patients tolerate Imeglimin well, but possible effects include:
Gastrointestinal: Nausea, diarrhea, or abdominal discomfort (usually temporary).
Neurological: Mild headache, itching, or dizziness (rare).
Hypoglycemia: Rare when used alone, but may occur when combined with insulin or sulfonylureas.
Frequently Asked Questions (FAQs)
Q: Can Imeglimin be taken with Metformin?
A: Yes. Clinical studies show improved glycemic control when Imeglimin is combined with Metformin in patients not adequately controlled on monotherapy.
Q: Could it replace insulin?
A: No. Imeglimin is indicated for Type 2 Diabetes and is not suitable for Type 1 Diabetes or diabetic ketoacidosis, where insulin therapy is required.
Q: How quickly can I expect my HbA1c to drop?
A: Blood glucose improvement may be seen within 2–4 weeks, while HbA1c reduction typically occurs over about 3 months with consistent use.
Q: What should I do if I miss a dose?
A: Take it as soon as you remember. If it is close to the next dose, skip the missed dose. Do not take a double dose.
Q: Will I lose weight with Imeglimin?
A: Imeglimin is generally weight-neutral. Some patients may notice minor weight changes due to improved metabolic control.
